or Try an Advanced Search...

    Preclinical Product Stocks List

    Symbol Grade Name % Change
    ZYME D Zymeworks Inc. 0.43
    EBS C Emergent Biosolutions, Inc. 5.14
    OMER C Omeros Corporation -1.34
    CLDX C Celldex Therapeutics, Inc. -0.66
    XENE C Xenon Pharmaceuticals Inc. -0.18
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Medicine Cancer Immune System Immunology Monoclonal Antibodies Monoclonal Antibody Solid Tumors Acne Addiction Advanced Breast Cancer Alipogene Tiparvovec Analgesics Anthrax Anthrax Vaccines Antibody Antibody Drug Conjugate Arthroscopy Biodefense Biological Systems

    Related ETFs - A few ETFs which own one or more of the above listed Preclinical Product stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 5.35
    IBRN D iShares Neuroscience and Healthcare ETF 4.2
    SBIO D ALPS Medical Breakthroughs ETF 3.79
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 1.69
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.96
    View all Preclinical Product ETFs...
    Compare ETFs
    Compare IBRN to LABD Compare IBRN to SBIO Compare PBE to IBRN

        Preclinical Product Stocks Recent News

        Date Stock Title
        May 5 ZYME Zymeworks Inc. (NASDAQ:ZYME) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
        May 3 ZYME Zymeworks Inc. (ZYME) Q1 2024 Earnings Call Transcript
        May 2 ZYME Zymeworks files automatic mixed securities shelf
        May 2 ZYME Zymeworks GAAP EPS of -$0.42 misses by $0.10, revenue of $10.03M misses by $6.4M
        May 2 ZYME Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
        May 2 XENE Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
        May 2 EBS Q1 2024 Emergent BioSolutions Inc Earnings Call
        May 2 EBS Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
        May 2 EBS Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
        May 2 EBS Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
        May 2 EBS PRESS DIGEST- Wall Street Journal - May 2
        May 2 EBS Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 1 EBS Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
        May 1 ZYME Zymeworks Q1 2024 Earnings Preview
        May 1 EBS Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
        May 1 EBS Emergent Biosolutions Non-GAAP EPS of $0.59 beats by $1.45, revenue of $300.4M beats by $75.9M
        May 1 EBS Emergent BioSolutions Reports First Quarter 2024 Financial Results
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Medicine Cancer Immune System Immunology Monoclonal Antibodies Monoclonal Antibody Solid Tumors Acne Addiction Advanced Breast Cancer Alipogene Tiparvovec Analgesics Anthrax Anthrax Vaccines Antibody Antibody Drug Conjugate Arthroscopy Biodefense Biological Systems
        Preclinical Product

        Browse All Tags